Switching to E-cigarettes in African-American Smokers
Status:
Not yet recruiting
Trial end date:
2025-08-30
Target enrollment:
Participant gender:
Summary
The objectives of this application are to 1) compare short- and long-term harm reduction and
abuse liability potential of a nicotine salt pod-based electronic cigarettes (EC) in African
American (AA) exclusive EC, dual cig-EC, and exclusive cig users, 2) characterize factors
that predict who switches fully, partially, or not at all, and 3) examine if harm reduction
can be further enhanced by treating dual users with varenicline (VAR) to eliminate cigarette
smoking.